Flora Growth Cannabis Expands European Presence With Strategic Supply Agreement For Medical Marijuana
Flora Growth Corp. (NASDAQ:FLGC) announced Wednesday a supply agreement with Blossom Genetics to bring Colombian medical cannabis to the German market.
What Happened: This collaboration will introduce two strains, Chemmy Jones and Northern Lights, to the European country. The move follows the company’s recent acquisition of Germany-based TruHC Pharma GmbH in response to the country’s recent cannabis reform.
Flora’s wholly-owned subsidiaries have been active in Germany since 2017, being among the first to obtain medical cannabis licenses in the country. Flora also holds an EU-GMP facility in Germany and has a distribution network with access to over 1,200 pharmacies nationwide.
Read Also: Flora Growth Q2 Revenue …